93. 原発性胆汁性胆管炎 Primary biliary cholangitis Clinical trials / Disease details

臨床試験数 : 298 / 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115

8 trials found

diseases per page:

Showing 1 to 8 of 8 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05751967 (ClinicalTrials.gov)	February 22, 2023	13/12/2022	Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis	A Prospective, Multi-center, Randomized, Double-blind, Placebo-controlled Study: FenofibrateCombined ...	Primary Biliary Cholangitis	Drug: Placebo Combined With Ursodeoxycholic Acid;Drug: Fenofibrate Combined With Ursodeoxycholic Acid ...	Xijing Hospital of Digestive Diseases	NULL	Recruiting	18 Years	75 Years	All	150	Phase 3	China
2	NCT05749822 (ClinicalTrials.gov)	February 17, 2023	29/12/2022	Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis	FenofibrateCombined With Ursodeoxycholic Acid in Compensated Cirrhosis Patients With Primary Biliary ...	Primary Biliary Cholangitis	Drug: Fenofibrate 200mg;Drug: Placebo;Drug: UDCA	Xijing Hospital of Digestive Diseases	NULL	Recruiting	18 Years	75 Years	All	104	Phase 2/Phase 3	China
3	ChiCTR1800020160	2018-12-20	2018-12-18	Clinical research for fenofibrate in the treatment of refractory primary biliary cirrhosis	Clinical research for fenofibrate in the treatment of refractory primary biliary cirrhosis	Primary Biliary Cirrhosis	1:Fenofibrate+UDCA;2:UDCA;	Peking Union Medical College Hosipital	NULL	Recruiting	18	65	Both	1:20;2:20;		China
4	NCT02823353 (ClinicalTrials.gov)	April 8, 2016	28/1/2016	Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis	Fenofibratein Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis: a Randomized Contr ...	Primary Biliary Cirrhosis	Drug: Fenofibrate;Drug: UDCA	Xijing Hospital of Digestive Diseases	NULL	Completed	18 Years	70 Years	All	117	Phase 3	China
5	NCT02823366 (ClinicalTrials.gov)	January 2016	28/1/2016	Fenofibratefor Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxych ...		Primary Biliary Cirrhosis	Drug: Fenofibrate;Drug: UDCA	Xijing Hospital of Digestive Diseases	NULL	Recruiting	18 Years	70 Years	All	104	Phase 3	China
6	NCT02965911 (ClinicalTrials.gov)	January 2016	15/11/2016	Efficacy and Safety of FenofibrateCombined With UDCA in PBC Patients With an Incomplete Biochemical ...	A Randomized Controlled Clinical Trial on the Efficacy and Safety of FenofibrateCombined With Ursode ...	Primary Biliary Cirrhosis	Drug: Fenofibrate;Drug: UDCA	Beijing 302 Hospital	NULL	Withdrawn	18 Years	65 Years	All	0	Phase 1/Phase 2	China
7	NCT01141296 (ClinicalTrials.gov)	April 2011	8/6/2010	Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis	Randomized Controlled Study of Fenofibratein Combination With Ursodeoxycholic Acid in Primary Biliar ...	Primary Biliary Cirrhosis	Drug: fenofibrate;Drug: placebo	University of Miami	Mayo Clinic	Withdrawn	21 Years	75 Years	Both	0	Phase 2	United States
8	NCT00575042 (ClinicalTrials.gov)	August 2007	13/12/2007	Use of Fenofibrate for Primary Biliary Cirrhosis	Pilot Study of Fenofibrate for Primary Biliary Cirrhosis	Primary Biliary Cirrhosis	Drug: Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)	University of Florida	The PBCers Organization;Shionogi Inc.	Completed	21 Years	75 Years	All	20	Phase 2	United States

First Previous1Next Last